BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 30289422)

  • 1. Qualitative analysis of antibody-drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs.
    Källsten M; Hartmann R; Artemenko K; Lind SB; Lehmann F; Bergquist J
    Analyst; 2018 Nov; 143(22):5487-5496. PubMed ID: 30289422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of triple quadrupole mass spectrometry for the characterization of antibody-drug conjugates.
    Källsten M; Pijnappel M; Hartmann R; Lehmann F; Kovac L; Lind SB; Bergquist J
    Anal Bioanal Chem; 2019 May; 411(12):2569-2576. PubMed ID: 30848315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
    Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
    J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
    Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
    Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-to-antibody ratio (DAR) and drug load distribution by hydrophobic interaction chromatography and reversed phase high-performance liquid chromatography.
    Ouyang J
    Methods Mol Biol; 2013; 1045():275-83. PubMed ID: 23913154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALDI-MS: a Rapid and Reliable Method for Drug-to-Antibody Ratio Determination of Antibody-Drug Conjugates.
    Abedi M; Ahangari Cohan R; Mahboudi F; Shafiee Ardestani M; Davami F
    Iran Biomed J; 2019 Nov; 23(6):395-403. PubMed ID: 31104399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is hydrophobic interaction chromatography the most suitable technique to characterize site-specific antibody-drug conjugates?
    D'Atri V; Pell R; Clarke A; Guillarme D; Fekete S
    J Chromatogr A; 2019 Feb; 1586():149-153. PubMed ID: 30554777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. I - Optimization of separation conditions.
    Sarrut M; Corgier A; Fekete S; Guillarme D; Lascoux D; Janin-Bussat MC; Beck A; Heinisch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():103-111. PubMed ID: 27426266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
    Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native size-exclusion chromatography-mass spectrometry: suitability for antibody-drug conjugate drug-to-antibody ratio quantitation across a range of chemotypes and drug-loading levels.
    Jones J; Pack L; Hunter JH; Valliere-Douglass JF
    MAbs; 2020; 12(1):1682895. PubMed ID: 31769727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of antibody-drug conjugates by comprehensive on-line two-dimensional hydrophobic interaction chromatography x reversed phase liquid chromatography hyphenated to high resolution mass spectrometry. II- Identification of sub-units for the characterization of even and odd load drug species.
    Sarrut M; Fekete S; Janin-Bussat MC; Colas O; Guillarme D; Beck A; Heinisch S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():91-102. PubMed ID: 27426265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-to-antibody determination for an antibody-drug-conjugate utilizing cathepsin B digestion coupled with reversed-phase high-pressure liquid chromatography analysis.
    Adamo M; Sun G; Qiu D; Valente J; Lan W; Song H; Bolgar M; Katiyar A; Krishnamurthy G
    J Chromatogr A; 2017 Jan; 1481():44-52. PubMed ID: 28017567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate determination of drug-to-antibody ratio of interchain cysteine-linked antibody-drug conjugates by LC-HRMS.
    Li K; Zhang Z; Lin ZJ; Shi H; Ma Y
    Anal Bioanal Chem; 2020 Feb; 412(4):833-840. PubMed ID: 31872274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Middle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation.
    Chen B; Lin Z; Zhu Y; Jin Y; Larson E; Xu Q; Fu C; Zhang Z; Zhang Q; Pritts WA; Ge Y
    Anal Chem; 2019 Sep; 91(18):11661-11669. PubMed ID: 31442030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Translational Application of an Integrated, Mechanistic Model of Antibody-Drug Conjugate Pharmacokinetics.
    Sukumaran S; Zhang C; Leipold DD; Saad OM; Xu K; Gadkar K; Samineni D; Wang B; Milojic-Blair M; Carrasco-Triguero M; Rubinfeld B; Fielder P; Lin K; Ramanujan S
    AAPS J; 2017 Jan; 19(1):130-140. PubMed ID: 27679517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer.
    Abdollahpour-Alitappeh M; Lotfinia M; Bagheri N; Sineh Sepehr K; Habibi-Anbouhi M; Kobarfard F; Balalaie S; Foroumadi A; Abbaszadeh-Goudarzi G; Abbaszadeh-Goudarzi K; Abolhassani M
    J Cell Physiol; 2019 Mar; 234(3):2693-2704. PubMed ID: 30246298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Native mass spectrometry and ion mobility characterization of trastuzumab emtansine, a lysine-linked antibody drug conjugate.
    Marcoux J; Champion T; Colas O; Wagner-Rousset E; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Protein Sci; 2015 Aug; 24(8):1210-23. PubMed ID: 25694334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Analytical Methods for Antibody-Drug Conjugates Produced by Chemical Site-Specific Conjugation: First-Generation AJICAP.
    Matsuda Y; Robles V; Malinao MC; Song J; Mendelsohn BA
    Anal Chem; 2019 Oct; 91(20):12724-12732. PubMed ID: 31478640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging mass spectrometry for the precise design of antibody-drug conjugates.
    Fujiwara Y; Furuta M; Manabe S; Koga Y; Yasunaga M; Matsumura Y
    Sci Rep; 2016 Apr; 6():24954. PubMed ID: 27098163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.